Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06. | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 698 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
16.06. | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 824 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 541 |
NVIDIA | 507 |
LILIUM | 451 |
NOVO NORDISK | 384 |
BAYER | 367 |
EVOTEC | 298 |
BYD | 297 |
TUI | 276 |
PALANTIR TECHNOLOGIES | 259 |
D-WAVE QUANTUM | 254 |
VOLKSWAGEN | 239 |
MICROSTRATEGY | 234 |
NEL | 147 |
AIXTRON SE | 144 |
RWE | 144 |
RHEINMETALL | 143 |
XIAOMI | 138 |
BASF | 135 |
SUPER MICRO COMPUTER | 126 |
ATOS | 125 |
AMAZON | 124 |
COMMERZBANK | 123 |
DEUTSCHE TELEKOM | 118 |
PLUG POWER | 118 |
FREYR BATTERY | 112 |